| dc.contributor.author | Karita, E | |
| dc.contributor.author | Anzala, O | |
| dc.contributor.author | Gazzard, B | |
| dc.date.accessioned | 2015-02-23T11:28:50Z | |
| dc.date.available | 2015-02-23T11:28:50Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Karita, Etienne, et al. "Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G (NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers." AIDS research and human retroviruses 30.S1 (2014): A85-A85. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11295/80695 | |
| dc.description.abstract | Development of vaccines that stimulate sustained humoral and/or cellular
immunity at mucosal HIV entry points is critical in the quest for an HIV vaccine. To achieve
this goal, we are investigating replication-competent viral vectors for mucosal delivery that .............................. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | University of Nairobi | en_US |
| dc.title | Clinical safety and immunogenicity of two hiv vaccines sev-g (np) and ad35-grin in HIV-uninfected, healthy adult volunteers | en_US |
| dc.type | Article | en_US |
| dc.type.material | es | en_US |
